These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36010557)

  • 1. Neuro-Axonal Damage and Alteration of Blood-Brain Barrier Integrity in COVID-19 Patients.
    Zingaropoli MA; Iannetta M; Piermatteo L; Pasculli P; Latronico T; Mazzuti L; Campogiani L; Duca L; Ferraguti G; De Michele M; Galardo G; Pugliese F; Antonelli G; Andreoni M; Sarmati L; Lichtner M; Turriziani O; Ceccherini-Silberstein F; Liuzzi GM; Mastroianni CM; Ciardi MR
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series.
    Edén A; Kanberg N; Gostner J; Fuchs D; Hagberg L; Andersson LM; Lindh M; Price RW; Zetterberg H; Gisslén M
    Neurology; 2021 Jan; 96(2):e294-e300. PubMed ID: 33004602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of Neurological Damage: From Acute Stage to Post-Acute Sequelae of COVID-19.
    Zingaropoli MA; Pasculli P; Barbato C; Petrella C; Fiore M; Dominelli F; Latronico T; Ciccone F; Antonacci M; Liuzzi GM; Talarico G; Bruno G; Galardo G; Pugliese F; Lichtner M; Mastroianni CM; Minni A; Ciardi MR
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759493
    [No Abstract]   [Full Text] [Related]  

  • 4. CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome.
    Guasp M; Muñoz-Sánchez G; Martínez-Hernández E; Santana D; Carbayo Á; Naranjo L; Bolós U; Framil M; Saiz A; Balasa M; Ruiz-García R; Sánchez-Valle R;
    Front Immunol; 2022; 13():866153. PubMed ID: 35479062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae?
    Bozzetti S; Ferrari S; Zanzoni S; Alberti D; Braggio M; Carta S; Piraino F; Gabbiani D; Girelli D; Nocini R; Monaco S; Crisafulli E; Mariotto S
    Immunol Res; 2021 Dec; 69(6):553-557. PubMed ID: 34363587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.
    Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E
    Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations.
    Bonetto V; Pasetto L; Lisi I; Carbonara M; Zangari R; Ferrari E; Punzi V; Luotti S; Bottino N; Biagianti B; Moglia C; Fuda G; Gualtierotti R; Blasi F; Canetta C; Montano N; Tettamanti M; Camera G; Grimoldi M; Negro G; Rifino N; Calvo A; Brambilla P; Biroli F; Bandera A; Nobili A; Stocchetti N; Sessa M; Zanier ER
    Front Immunol; 2022; 13():1070379. PubMed ID: 36591311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms.
    Edén A; Grahn A; Bremell D; Aghvanyan A; Bathala P; Fuchs D; Gostner J; Hagberg L; Kanberg N; Kanjananimmanont S; Lindh M; Misaghian S; Nilsson S; Schöll M; Sigal G; Stentoft E; Studahl M; Yilmaz A; Wang M; Stengelin M; Zetterberg H; Gisslén M
    JAMA Netw Open; 2022 May; 5(5):e2213253. PubMed ID: 35604688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes.
    Lennol MP; Ashton NJ; Moreno-Pérez O; García-Ayllón MS; Ramos-Rincon JM; Andrés M; León-Ramírez JM; Boix V; Gil J; Blennow K; Merino E; Zetterberg H; Sáez-Valero J
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection.
    Hanson BA; Visvabharathy L; Ali ST; Kang AK; Patel TR; Clark JR; Lim PH; Orban ZS; Hwang SS; Mattoon D; Batra A; Liotta EM; Koralnik IJ
    Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35256481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid in the CSF of COVID-19 hospitalized patients.
    Normandin E; Holroyd KB; Collens SI; Shaw BM; Siddle KJ; Adams G; Rudy M; Solomon IH; Anahtar MN; Lemieux JE; Trombetta BA; Kivisakk P; Arnold SE; Rapalino O; Piantadosi AL; Sen P; Rosenberg ES; Branda J; Sabeti PC; Mukerji SS
    J Neurol Sci; 2021 Nov; 430():120023. PubMed ID: 34678659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofilament Light Chain Levels in Multiple Sclerosis Correlate With Lesions Containing Foamy Macrophages and With Acute Axonal Damage.
    van den Bosch A; Fransen N; Mason M; Rozemuller AJ; Teunissen C; Smolders J; Huitinga I
    Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35241571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects.
    Constant O; Barthelemy J; Bolloré K; Tuaillon E; Gosselet F; Chable-Bessia C; Merida P; Muriaux D; Van de Perre P; Salinas S; Simonin Y
    Front Immunol; 2021; 12():697329. PubMed ID: 34386007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients.
    Alexopoulos H; Magira E; Bitzogli K; Kafasi N; Vlachoyiannopoulos P; Tzioufas A; Kotanidou A; Dalakas MC
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32978291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations.
    Verde F; Milone I; Bulgarelli I; Peverelli S; Colombrita C; Maranzano A; Calcagno N; Ticozzi N; Perego GB; Parati G; Torresani E; Ratti A; Silani V
    J Neurol; 2022 Nov; 269(11):5691-5701. PubMed ID: 35781535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019.
    Mohammadhosayni M; Sadat Mohammadi F; Ezzatifar F; Mahdavi Gorabi A; Khosrojerdi A; Aslani S; Hemmatzadeh M; Yazdani S; Arabi M; Marofi F; Jadidi-Niaragh F; Shomali N; Mohammadi H
    Int Immunopharmacol; 2021 Nov; 100():108076. PubMed ID: 34450402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of the axonal injury marker neurofilament light protein are not influenced by blood-brain barrier permeability.
    Kalm M; Boström M; Sandelius Å; Eriksson Y; Ek CJ; Blennow K; Björk-Eriksson T; Zetterberg H
    Brain Res; 2017 Aug; 1668():12-19. PubMed ID: 28522263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up.
    Kanberg N; Simrén J; Edén A; Andersson LM; Nilsson S; Ashton NJ; Sundvall PD; Nellgård B; Blennow K; Zetterberg H; Gisslén M
    EBioMedicine; 2021 Aug; 70():103512. PubMed ID: 34333238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis.
    Le ND; Muri L; Grandgirard D; Kuhle J; Leppert D; Leib SL
    J Neuroinflammation; 2020 Oct; 17(1):293. PubMed ID: 33028339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.
    Jessen Krut J; Mellberg T; Price RW; Hagberg L; Fuchs D; Rosengren L; Nilsson S; Zetterberg H; Gisslén M
    PLoS One; 2014; 9(2):e88591. PubMed ID: 24523921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.